Syndax Pharmaceuticals
SNDX
SNDX
130 hedge funds and large institutions have $1.08B invested in Syndax Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 55 increasing their positions, 43 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
8% less funds holding
Funds holding: 142 → 130 (-12)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
48% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 25
Holders
130
Holding in Top 10
3
Calls
$5.55M
Puts
$3.82M
Top Buyers
| 1 | +$45.8M | |
| 2 | +$33.2M | |
| 3 | +$21.3M | |
| 4 |
CC
Casdin Capital
New York
|
+$12.3M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$12M |
Top Sellers
| 1 | -$26M | |
| 2 | -$16.8M | |
| 3 | -$16M | |
| 4 |
VA
VR Adviser
New York
|
-$11.7M |
| 5 |
Two Sigma Investments
New York
|
-$7.9M |